The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×

Sections

Rationale for Treating ASD | Psychotherapy Approaches | Pharmacological Approaches | Implications of the DSM-5 Diagnosis | Challenges for Treating ASD | Conclusion | References

Excerpt

Acute stress disorder (ASD) was introduced in the fourth edition of the Diagnostic and Statistical Manual of Mental Disorders, DSM-IV (American Psychiatric Association 1994). The purpose of this diagnosis was to describe severe posttraumatic stress responses within the first month following a trauma and also to identify individuals at risk of developing chronic posttraumatic stress disorder (PTSD) following exposure to a traumatic event (Koopman et al. 1995). The need to have a separate diagnosis describing initial PTSD was recognized because one cannot formally diagnose PTSD within a month of trauma exposure. There was concern that severe stress reactions were not being adequately addressed because they were not diagnosed. Accordingly, the diagnosis was introduced with criteria that largely resembled PTSD criteria, with the exception that considerable emphasis was placed on dissociative symptoms as an additional cluster (Harvey and Bryant 2002). The introduction of this new diagnosis led to an unprecedented level of research on early interventions for PTSD reactions occurring in the initial weeks following trauma exposure. In this chapter I provide an overview of the current evidence for treating ASD and potential changes to understanding this evidence in light of marked changes to the diagnostic criteria in DSM-5 (American Psychiatric Association 2013).

Access content

To read the fulltext, please use one of the options below to sign in or purchase access.
  • Institutional Login
  • Sign in via OpenAthens
  • Register for access
  • Please login/register if you wish to pair your device and check access availability.

    Not a subscriber?

    Subscribe Now / Learn More

    PsychiatryOnline subscription options offer access to the DSM-5 library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.

    Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).